Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Patient Voices
Panel: Fighting Dementia in Black Communities Through Education
The Pain of Being Misdiagnosed: Early-Onset Alzheimer’s vs. Lewy Body Dementia
‘Misdiagnosed by Six Different Neurologists:’ Don Kent’s LBD Journey
Phil’s Journal: Dispatch from AAIC, Day One
Phil’s Journal: Before AAIC In Amsterdam, Leading Alzheimer’s Advocates Weigh In
Phil’s Journal: What Is ‘Quality of Life?’ A Sad Farewell and a Tough Deciscion
Laurie Scherrer on Early Signs, Current Symptoms, and Living Well With Early-Onset Alzheimer’s, FTD
‘How I First Knew Something Was Wrong:’ An Oral History of Early Dementia
‘Not Your Grandma’s Alzheimer’s’: Ivy League Leader Paves New Path Towards Advocacy
A Trial Participant’s Inside Look at New Alzheimer’s Drug Leqembi
Phil’s Journal: Another Alzheimer’s Drug, Lecanemab, Wins Early Approval—So, What Now?
Phil’s Journal: Why Voices of Alzheimer’s? Because ‘Silence Equals Death’
When MCI Cut His Career As a Prosecutor Short, He Set Out on a New Journey
His Diagnosis: Early-Onset Alzheimer’s. The Suspected Cause? Lyme Disease
Phil’s Journal: The Face of Alzheimer’s Is Changing — Are We Ready?
Previous
2
3
4
Next
Page load link
Go to Top